Overview

Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
To investigate the pharmacokinetics of levodopa when administered concomitantly with BIA 9-1067 or 1 hour after.
Phase:
Phase 1
Details
Lead Sponsor:
Bial - Portela C S.A.
Treatments:
Carbidopa
Carbidopa, levodopa drug combination
Levodopa
Opicapone